IT1302307B1 - Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil - Google Patents

Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil

Info

Publication number
IT1302307B1
IT1302307B1 IT1998RM000566A ITRM980566A IT1302307B1 IT 1302307 B1 IT1302307 B1 IT 1302307B1 IT 1998RM000566 A IT1998RM000566 A IT 1998RM000566A IT RM980566 A ITRM980566 A IT RM980566A IT 1302307 B1 IT1302307 B1 IT 1302307B1
Authority
IT
Italy
Prior art keywords
glucose
improving
composition
antioxidant activity
including acetyl
Prior art date
Application number
IT1998RM000566A
Other languages
English (en)
Italian (it)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11406116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1302307(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Priority to IT1998RM000566A priority Critical patent/IT1302307B1/it
Publication of ITRM980566A0 publication Critical patent/ITRM980566A0/it
Priority to MA25719A priority patent/MA25284A1/fr
Priority to PL346318A priority patent/PL212737B1/pl
Priority to TR2001/00610T priority patent/TR200100610T2/xx
Priority to ES99939612T priority patent/ES2188214T5/es
Priority to JP2000567099A priority patent/JP4361215B2/ja
Priority to HK02101323.4A priority patent/HK1039730A1/zh
Priority to AU53871/99A priority patent/AU773424B2/en
Priority to EP99939612A priority patent/EP1112005B2/en
Priority to PT99939612T priority patent/PT1112005E/pt
Priority to CZ2001541A priority patent/CZ2001541A3/cs
Priority to AT99939612T priority patent/ATE228312T1/de
Priority to SI9930109T priority patent/SI1112005T1/xx
Priority to IL14143599A priority patent/IL141435A0/xx
Priority to DK99939612.0T priority patent/DK1112005T4/da
Priority to KR1020017002527A priority patent/KR20010079699A/ko
Priority to US09/786,153 priority patent/US6365622B1/en
Priority to PCT/IT1999/000268 priority patent/WO2000011968A1/en
Priority to CN99810437A priority patent/CN1315835A/zh
Priority to BR9913288-5A priority patent/BR9913288A/pt
Priority to HU0102909A priority patent/HU229165B1/hu
Priority to SK263-2001A priority patent/SK2632001A3/sk
Priority to EEP200100113A priority patent/EE200100113A/xx
Priority to CA002341973A priority patent/CA2341973C/en
Priority to DE69904208T priority patent/DE69904208T3/de
Priority to TNTNSN99163A priority patent/TNSN99163A1/fr
Priority to ARP990104347A priority patent/AR022076A1/es
Publication of ITRM980566A1 publication Critical patent/ITRM980566A1/it
Publication of IT1302307B1 publication Critical patent/IT1302307B1/it
Application granted granted Critical
Priority to IS5850A priority patent/IS5850A/is
Priority to NO20010954A priority patent/NO20010954L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
IT1998RM000566A 1998-09-01 1998-09-01 Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil IT1302307B1 (it)

Priority Applications (29)

Application Number Priority Date Filing Date Title
IT1998RM000566A IT1302307B1 (it) 1998-09-01 1998-09-01 Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
MA25719A MA25284A1 (fr) 1998-09-01 1999-08-06 Composition antioxydante, y compris l'acide de l'acetylene, l-carnitine qui ameliore l'utilisation metabolique du glucose.
DE69904208T DE69904208T3 (de) 1998-09-01 1999-08-19 Antioxidative mischung bestehend aus acetyl l-carnitin und alpha-liponsäure
IL14143599A IL141435A0 (en) 1998-09-01 1999-08-19 ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID
PCT/IT1999/000268 WO2000011968A1 (en) 1998-09-01 1999-08-19 ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID
ES99939612T ES2188214T5 (es) 1998-09-01 1999-08-19 Composicion antioxidante que comprende acetil l-carnitina y acido alfa-lipoico.
JP2000567099A JP4361215B2 (ja) 1998-09-01 1999-08-19 アセチルL−カルニチンおよびα−リポ酸を含む抗酸化組成物
HK02101323.4A HK1039730A1 (zh) 1998-09-01 1999-08-19 含乙酰L-肉碱和α-硫辛酸的抗氧化劑組合物
AU53871/99A AU773424B2 (en) 1998-09-01 1999-08-19 Antioxidant composition comprising acetyl L-carnitine and alpha-lipoic acid
EP99939612A EP1112005B2 (en) 1998-09-01 1999-08-19 Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid
PT99939612T PT1112005E (pt) 1998-09-01 1999-08-19 Composicao antioxidante contendo acetil l-carnitina e acido alfa-lipoico
CZ2001541A CZ2001541A3 (cs) 1998-09-01 1999-08-19 Antioxidační přípravek obsahující acetyl-L-karnitin a kyselinu alfa-lipoovou
AT99939612T ATE228312T1 (de) 1998-09-01 1999-08-19 Antioxidative mischung bestehend aus acetyl l- carnitin und alpha-liponsäure
SI9930109T SI1112005T1 (en) 1998-09-01 1999-08-19 Antioxidant composition comprising acetyl l-carnitine and alpha-lipoic acid
PL346318A PL212737B1 (pl) 1998-09-01 1999-08-19 Kompozycja przeciwutleniajaca zawierajaca acetylo-L-karnityne oraz kwas α-liponowy i jej zastosowanie
DK99939612.0T DK1112005T4 (da) 1998-09-01 1999-08-19 Antioxiderende præparat, som omfatter acetyl-L-carnitin og alfa-lipoinsyre
KR1020017002527A KR20010079699A (ko) 1998-09-01 1999-08-19 아세틸 L-카르니틴 및 α-리포산을 포함하는 산화 방지조성물
US09/786,153 US6365622B1 (en) 1998-09-01 1999-08-19 Antioxidant composition comprising acetyl L-carnitine and α-lipoic acid
TR2001/00610T TR200100610T2 (tr) 1998-09-01 1999-08-19 Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
CN99810437A CN1315835A (zh) 1998-09-01 1999-08-19 含乙酰L-肉碱和α-硫辛酸的抗氧化剂组合物
BR9913288-5A BR9913288A (pt) 1998-09-01 1999-08-19 Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico
HU0102909A HU229165B1 (en) 1998-09-01 1999-08-19 Antioxidant composition comprising acetil-l-carnitine and alpha-lipoic acid
SK263-2001A SK2632001A3 (en) 1998-09-01 1999-08-19 ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE ANDì (54) ALPHA-LIPOIC ACID
EEP200100113A EE200100113A (et) 1998-09-01 1999-08-19 Atsetüül-L-karnitiini ning alfa-lipohapet sisaldav oksüdeerumisvastane kompositsioon
CA002341973A CA2341973C (en) 1998-09-01 1999-08-19 Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
ARP990104347A AR022076A1 (es) 1998-09-01 1999-08-30 Composicion antioxidante constituida por acetil l-carnitina y acido alfa-lipoico para mejorar el aprovechamiento metabolico de la glucosa
TNTNSN99163A TNSN99163A1 (fr) 1998-09-01 1999-08-30 COMPOSITION ANTIOXYDANTE COMPRENANT L'ACETYL-CARNITINE ET L'ACIDE α -LIPOIQUE QUI AMELIORE L'UTILISATION METABOLIQUE DU GLUCOSE
IS5850A IS5850A (is) 1998-09-01 2001-02-16 Andoxunar samsetning sem samanstendur af asetýl L-karnitíni og alfa-lípósýru
NO20010954A NO20010954L (no) 1998-09-01 2001-02-26 Antioksidantsammensetning som innbefatter acetyl L-karnitin og <alfa>-lipoidsyre

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998RM000566A IT1302307B1 (it) 1998-09-01 1998-09-01 Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil

Publications (3)

Publication Number Publication Date
ITRM980566A0 ITRM980566A0 (it) 1998-09-01
ITRM980566A1 ITRM980566A1 (it) 2000-03-01
IT1302307B1 true IT1302307B1 (it) 2000-09-05

Family

ID=11406116

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998RM000566A IT1302307B1 (it) 1998-09-01 1998-09-01 Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil

Country Status (28)

Country Link
US (1) US6365622B1 (https=)
EP (1) EP1112005B2 (https=)
JP (1) JP4361215B2 (https=)
KR (1) KR20010079699A (https=)
CN (1) CN1315835A (https=)
AR (1) AR022076A1 (https=)
AT (1) ATE228312T1 (https=)
AU (1) AU773424B2 (https=)
BR (1) BR9913288A (https=)
CA (1) CA2341973C (https=)
CZ (1) CZ2001541A3 (https=)
DE (1) DE69904208T3 (https=)
DK (1) DK1112005T4 (https=)
EE (1) EE200100113A (https=)
ES (1) ES2188214T5 (https=)
HK (1) HK1039730A1 (https=)
HU (1) HU229165B1 (https=)
IL (1) IL141435A0 (https=)
IS (1) IS5850A (https=)
IT (1) IT1302307B1 (https=)
MA (1) MA25284A1 (https=)
NO (1) NO20010954L (https=)
PL (1) PL212737B1 (https=)
PT (1) PT1112005E (https=)
SK (1) SK2632001A3 (https=)
TN (1) TNSN99163A1 (https=)
TR (1) TR200100610T2 (https=)
WO (1) WO2000011968A1 (https=)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
WO2001021208A1 (en) 1999-09-23 2001-03-29 Juvenon Corporation Nutritional supplement for increased energy and stamina
CA2389623A1 (en) * 1999-11-03 2001-05-10 Juvenon, Inc. Method of treating benign forgetfulness
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
DE10036797A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Verwendung von Kombinationen mit einem Gehalt an Carnitinen
CN1477958A (zh) * 2000-10-31 2004-02-25 高露洁-棕榄公司 组合物及方法
JP2010142237A (ja) * 2000-10-31 2010-07-01 Colgate Palmolive Co 組成物及び方法
US20020076470A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US6555573B2 (en) 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
PL363426A1 (en) * 2001-03-09 2004-11-15 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
SE0102380D0 (sv) * 2001-07-02 2001-07-02 Macronova Ab Kräm för behandling av åldersförändringar i huden hos människa
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
NZ533439A (en) * 2001-12-19 2006-06-30 The Quigley Corp Methods for the treatment of peripheral neural and vascular ailments using flavonoid compositions
US20060127505A1 (en) * 2002-01-16 2006-06-15 David Haines Anti-inflammatory formulations
EP1476440A4 (en) * 2002-02-22 2005-06-01 Albany College Of Pharmacy METHODS AND COMPOUNDS USEFUL IN INHIBITION BY RADICAL AND / OR OXIDIZING AGGRESSION AND IN THE TREATMENT AND PREVENTION OF DISEASE
JP2006506361A (ja) * 2002-10-11 2006-02-23 クレアグリ, インコーポレイテッド カルニチンおよび酸化防止ポリフェノールの治療用組合せ
US7083813B2 (en) 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
DE10258239A1 (de) * 2002-12-13 2004-06-24 Degussa Ag Formulierung enthaltend alpha-Liponsäure(-Derivate) als alleinigen Wirkstoff bei nichtchronischen alkoholinduzierten Intoxikationen
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
US20040265345A1 (en) * 2003-06-30 2004-12-30 Perricone Nicholas V. Treatment of skin damage using acetyl carnitine and lipoic acid
US20050214413A1 (en) * 2003-08-26 2005-09-29 Mannatech, Inc. Methods and compositions for modified release of nutritional supplements
US7999003B2 (en) * 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
EP1706146B1 (en) * 2003-12-31 2013-08-21 K-Pax Pharmaceuticals, Inc. Nutrient compositions and use thereof for enhanced effectiveness of the immune system
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
JP5138380B2 (ja) * 2004-11-24 2013-02-06 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物における免疫応答を増大させる方法
WO2006058278A2 (en) * 2004-11-24 2006-06-01 Hill's Pet Nutrition, Inc. Methods for improving liver clearance of xenobiotic substances in an animal
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
DK1830883T3 (da) 2004-12-29 2013-11-25 Hills Pet Nutrition Inc Fremgangsmåde til at hæmme en nedgang i indlæring og/eller hukommelse hos dyr
US8148325B2 (en) * 2004-12-30 2012-04-03 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) * 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP5685362B2 (ja) * 2005-04-26 2015-03-18 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニSigma−Tau Industrie Farmaceutiche Riunite Societa Per Azioni 有痛性末梢糖尿病性神経障害の予防のためのアセチルl−カルニチン
EP1906912B1 (en) 2005-07-14 2012-08-15 Hill's Pet Nutrition, Inc. Method for prolonging the life of animals
US8318954B2 (en) * 2006-02-23 2012-11-27 Nou Life Sciences, Inc. Cleavable carnitine compound
CN101045048B (zh) * 2006-03-27 2011-05-18 中国科学院上海生命科学研究院 线粒体营养素组合物的应用
CN101057857B (zh) * 2006-04-21 2011-05-18 中国科学院上海生命科学研究院 一种预防与改善帕金森氏症的组合物及其制法
KR100811110B1 (ko) * 2007-02-21 2008-03-06 주식회사 디피아이 솔루션스 수분산성 α-리포산 캡슐 조성물을 함유하는 어류의 면역력증강용 사료첨가제 및 그 사용방법.
US20080226696A1 (en) * 2007-03-15 2008-09-18 Ben Treadwell Methods of improving learning abilities of aged companion animals
US20100255109A1 (en) * 2007-08-06 2010-10-07 Biogenics, Inc. Stabilized antioxidant particles, composition comprising the same and method for preparing the same
KR20090014568A (ko) * 2007-08-06 2009-02-11 (주)바이오제닉스 코팅된 알파리포산 입자, 이를 포함하는 조성물 및 그 제조방법
US20090054513A1 (en) * 2007-08-22 2009-02-26 Response Scientific, Inc. Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease
US7943163B2 (en) * 2007-08-22 2011-05-17 Response Scientific, Inc. Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes
KR100903549B1 (ko) * 2008-07-29 2009-06-23 주식회사 카이로제닉스 균질한 결정성의 아세틸-l-카르니틴과 티옥트산 칼륨염의 복합염, 이의 제조방법 및 이를 포함하는 약학적 조성물
US20110217252A1 (en) * 2008-11-11 2011-09-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
EP2389931A1 (en) * 2010-05-21 2011-11-30 Raw Materials Internatinal LLC Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
US9040082B2 (en) 2011-06-24 2015-05-26 K-Pax Pharmaceuticals, Inc. Compositions and methods for treatment of chronic fatigue
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
CA2858574C (en) 2011-12-07 2017-05-30 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US20140371280A1 (en) * 2013-03-15 2014-12-18 Shinichi Okuyama Method of treating diabetic peripheral neuropathy through amendment of pre-neuronal diabetic coagulative micro-angiopathy and neuronal deficiency of mitochondrial ATP production, and through induction of neuronal regeneration
US20190290609A1 (en) * 2014-03-19 2019-09-26 Epitech Group S.P.A. Pharmaceutical composition comprising palmitoylethanolamide and l-acetylcarnitine
WO2016065360A1 (en) * 2014-10-24 2016-04-28 Robert Shorr Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
NZ732058A (en) 2014-11-25 2023-06-30 Allergan Inc Stabilized omega-3 ophthalmic compositions
DK3277273T3 (da) * 2015-03-31 2020-04-14 Kolinpharma S P A Sammensætning til behandling af neuropatier og/eller neuropatisk smerte
US11639494B2 (en) 2015-08-24 2023-05-02 Vitrolife Sweden Ab Culture medium
US11998554B2 (en) * 2018-09-10 2024-06-04 URIACH ITALY S.r.l. Composition comprising lipoic acid and vitamin D for the prevention and the treatment of neurodegenerative diseases and peripheral neuropathies
CN111467385B (zh) * 2019-01-24 2022-05-17 深圳市华大农业应用研究院 组合物在预防或治疗神经退行性疾病中的用途
US12521407B2 (en) 2019-04-18 2026-01-13 Simo Rasi Composition for use in prevention or reduction of oxidative stress and neurodegenerative diseases
US12208077B2 (en) 2021-04-06 2025-01-28 Celagenex Research (India) Pvt. Ltd. Synergistic composition for potentiating stabilized ATP
CN112999220B (zh) * 2021-04-07 2022-12-13 中国人民解放军南部战区总医院 α-硫辛酸在作为和/或制备金属β-内酰胺酶抑制剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
WO1997002041A1 (en) * 1995-07-03 1997-01-23 Crandall Wilson T Transdermal and oral treatment of androgenic alopecia
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ. コスバブ,ジョン 血管変性性疾患の予防および処置のための組成物および方法
IT1291113B1 (it) 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5916912A (en) 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress

Also Published As

Publication number Publication date
EP1112005B2 (en) 2010-03-24
BR9913288A (pt) 2001-05-22
CA2341973C (en) 2009-05-12
DE69904208T3 (de) 2010-09-30
DE69904208D1 (de) 2003-01-09
DK1112005T3 (da) 2002-12-30
TNSN99163A1 (fr) 2005-11-10
PT1112005E (pt) 2003-03-31
AU773424B2 (en) 2004-05-27
US6365622B1 (en) 2002-04-02
KR20010079699A (ko) 2001-08-22
EE200100113A (et) 2002-06-17
IS5850A (is) 2001-02-16
CA2341973A1 (en) 2000-03-09
CN1315835A (zh) 2001-10-03
JP4361215B2 (ja) 2009-11-11
AR022076A1 (es) 2002-09-04
ES2188214T5 (es) 2010-06-08
NO20010954L (no) 2001-04-25
IL141435A0 (en) 2002-03-10
ITRM980566A1 (it) 2000-03-01
ES2188214T3 (es) 2003-06-16
DK1112005T4 (da) 2010-06-14
NO20010954D0 (no) 2001-02-26
MA25284A1 (fr) 2001-12-31
JP2002523435A (ja) 2002-07-30
AU5387199A (en) 2000-03-21
HUP0102909A3 (en) 2002-12-28
TR200100610T2 (tr) 2001-07-23
DE69904208T2 (de) 2003-08-28
PL346318A1 (en) 2002-01-28
SK2632001A3 (en) 2001-08-06
HK1039730A1 (zh) 2002-05-10
CZ2001541A3 (cs) 2001-09-12
ATE228312T1 (de) 2002-12-15
HUP0102909A2 (hu) 2002-03-28
PL212737B1 (pl) 2012-11-30
ITRM980566A0 (it) 1998-09-01
WO2000011968A1 (en) 2000-03-09
EP1112005B1 (en) 2002-11-27
WO2000011968A8 (en) 2000-05-11
EP1112005A1 (en) 2001-07-04
HU229165B1 (en) 2013-09-30

Similar Documents

Publication Publication Date Title
IT1302307B1 (it) Composizione ad attivita&#39; antiossidante ed atta a migliorarel&#39;utilizzazione metabolica del glucosio, comprendente acetil
GB2341960B (en) Medical calculator
HUP0103714A3 (en) Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity, medicaments containing them and their use
FI932844A7 (fi) Saniteettiside, jolla on poikittaisesti segmentoitu sydän
ID21115A (id) Isokuinolin-3-karboksamida tersubstitusi, pembuatannya serta penggunaannya sebagai obat
NO20015262L (no) 3&lt;alfa&gt;-Hydroksy-3&lt;beta&gt;-metoksymetyl-21-heterocyklisk substituerte steroider med bedövende aktivitet
AU4198199A (en) Absorbent article with skin care composition
ITMI940018A0 (it) Eterobicicli ad attivita&#39; fungicida
IT8920013A0 (it) Nuovi piridazinoni ad attivita&#39; insetticida ed acaricida.
IT9019754A0 (it) Composizioni farmaceutiche,dietetiche o veterinarie ad attivita&#39; eumetabolica
AU5033300A (en) Absorbent article with skin care composition
IT1299197B1 (it) Composizione ad attivita&#39; antiossidante, antiproliferativa, energetica e atta a migliorare l&#39;utilizzazione metabolica del glucosio.
PT1122243E (pt) Novos imidazoles com actividades anti-inflamatoria
DE60026714D1 (de) Dünne damenbinde mit hoher stabilität
DE69901795D1 (de) Zusammensetzungen mit geringer hautreizung
NO20021856L (no) Koplingsdal
IT9047551A0 (it) Impiego di a-amminofluorochetoni per la preparazione di medicamenti ad attivita&#39; cardiovascolare e antipertensiva.
GB9802071D0 (en) Skin care composition
ITMI942219A0 (it) &#34;composti ad attivita&#39; cardiovascolare&#34;
ITMI980827A0 (it) Composizioni e sostanze ad attivita&#39; dermoproliferativa
ITMI941731A0 (it) Nuovi nitro-inibitori aventi attivita&#39; anti-infiammatoria
DK23598A (da) Skin care compositions comprising enzymes with reduced allergenicity.
IT1292182B1 (it) Composizione fitoterapica per uso dermatologico,in particolare ad attivita&#39; cicatrizzante
ITMI981512A1 (it) Composizioni farmaceutiche, dietetiche o alimenti funzionali ad attivita&#39; antiossidante
IT1289956B1 (it) Antrachinoni con attivita&#39; inibente le topoisomerasi

Legal Events

Date Code Title Description
0001 Granted